Amber Siegfried

Doctor of Medicine,  Mayo Clinic - Rochester 

Location: Germany

Consulting Services

Sales and Marketing Legal Support IT-Web-Mobile Technology Career Advice and Mentoring Grant Submission

Areas Of Interest

Levocarnitine Oncogene Protein rel LCM Lassa Complex Viruses Serotonin-Specific Neurotransmitter Transporters Voluntary Health Agencies Sleep-Related Neurogenic Tachypnea Mutations, Point Intestinal Microbiota Transfers Monophosphate Mannose, Dolichol Pharmacogenomic Screening Nervous System Plumbism Cytokeratin 6 Porocarcinomas, Eccrine Cytochrome P450 Family 12 Implantations, Dental Prosthesis Spectrophotometry, Atomic Antigens, Ia-Like Proteins, Homeobox Anti-Vaccination Group Aortic Stiffnesses Meta-Analysis, Mixed Treatment Growth, Sustainable Nociception Test Lateral Nucleus of Amygdala PTLV-2 Dugesia Retinol-Binding Protein 1 Androgen Receptor Deficiency Cell Division Cycle Proteins Allergic Cutaneous Vasculitis Lacunar Infarct Respiratory Physiological Phenomenon Ly49D Antigen RNA Splicing Factors N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine Tranxilium N

Professional Narrative

Dr. Amber Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Director Medicine, Amgen 2006
Senior Director, Amgen 1987

Education

Master of Science in physician assistant, Perelman School of Medicine 1991
Bachelor of science in nursing, Yale School of Medicine 2001

Referees

Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02